DEXMEDETOMIDINE 100 ug/mL (Dexmedetomidine INJECTION, SOLUTION) 100 ug/mL

Dexmedetomidine 100 ug/mL is an injectable solution used for sedation and pain management. This medication is commonly administered intravenously for various medical procedures.

Strength

100 ug/mL

Pack Size

25 VIAL in 1 CARTON (16729-432-93) / 2 mL in 1 VIAL (16729-432-30)

Manufacturer / TM Owner

Accord Healthcare Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dexmedetomidine 100 ug/mL is primarily used for sedation in intensive care units and during medical procedures. It is also utilized for pain management and to reduce anxiety. The medication works by affecting certain areas of the brain to produce calming effects. What is Dexmedetomidine used for? It is often prescribed for patients who require sedation during surgery or other invasive procedures.

Side Effects

Common effects of Dexmedetomidine 100 ug/mL may include lowered blood pressure, slowed heart rate, and drowsiness. Some patients may experience nausea or vomiting. These effects are generally mild and temporary, but they can vary depending on the individual.

Precautions & Warnings

Dexmedetomidine 100 ug/mL should be used with caution in patients with low blood pressure or heart conditions. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Always inform your doctor about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Dexmedetomidine 100 ug/mL may interact with other sedatives, blood pressure medications, and heart rhythm medications. It is important to discuss all current medications with your healthcare provider to ensure safe use. Alcohol and certain CYP inhibitors may also affect the metabolism of Dexmedetomidine.

Frequently Asked Questions

Dexmedetomidine is used for sedation and pain management during medical procedures and in intensive care settings.

Dexmedetomidine is typically administered intravenously by a healthcare professional.

Common side effects may include lowered blood pressure, slowed heart rate, and drowsiness.

Dexmedetomidine may interact with other sedatives and blood pressure medications, so it is important to consult a healthcare provider.

Dexmedetomidine should be used with caution in patients with heart conditions or low blood pressure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.